OBJECTIVES: In patients with possible acute coronary syndromes, guidelines recommend routine provocative testing after negative cardiac biomarkers. We hypothesized that myocardial perfusion imaging would be low yield with limited short-term value and that early revascularization would not affect mortality.
METHODS: We identified consecutive patients referred from our emergency department between October 2004 and September 2011 who had myocardial perfusion imaging after negative troponin T tests and non-diagnostic ECGs. We assessed the incidence of abnormal myocardial perfusion imaging, coronary angiography, revascularization, and mortality.
RESULTS: In a cohort of 5354patients (58.7% female, age 59 Â± 13, 78.6% thrombolysis in myocardial infarction [TIMI] â‰¤2), 9% had >5% and 3.6% had >10% ischemic myocardium. Among patients with TIMI scores â‰¤2, 6.1% had >5% ischemic myocardium compared with 19.6% of patients with TIMI scores â‰¥3 (P<0.001). At 30 days, 7 patients were deceased, 187 had revascularization, and 6 had revascularization for an acute myocardial infarction. Over 3.4 Â± 1.9 years of follow-up, 347 patients died. In propensity-matched groups of patients with ischemia, there was no association between early revascularization and mortality (hazard ratio, 1.00; 95% confidence interval, 0.49-2.07).
CONCLUSIONS: Routine provocative testing to detect ischemia before emergency department discharge is low yield in patients with negative troponins and TIMI scores â‰¤2 and modest yield in patients with TIMI scores â‰¥3. In all patients, 30 days events are rare. Finally, in patients with ischemia, we are unable to demonstrate a mortality benefit with early revascularization.